Clinical trial
Effect of Bosentan on Exercise Capacity at High Altitude
NCT00432978 · VA Loma Linda Health Care System, U.S. Fed · Completed
Key facts
| NCT number | NCT00432978 |
|---|---|
| Title | Effect of Bosentan on Exercise Capacity at High Altitude |
| Official title | Effect of Bosentan on Exercise Capacity at High Altitude |
| Lead sponsor | VA Loma Linda Health Care System, U.S. Fed |
| Collaborators | Actelion Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Altitude, Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | Bosentan administration |
| Enrollment | 20 |
| Start date | Jul 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Feb 8, 2007 |
| Last update posted | Apr 18, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: